These results confirm a novel role for TRIM32 for glycolytic-mediated cell growth in both normal and tumor tissues and may pave the avenue for further studies in TRIM32KO mice to also understand if they may develop spontaneously less tumors with aging than their wild-type counterparts. Here, TRIM32 is linked to neoplasm.